Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1

Interventions

Gemcitabine 26 Specimen Handling 20 130-nm albumin-bound paclitaxel 18 Magnetic Resonance Spectroscopy 13 Irinotecan 13 Biopsy 12 Fluorouracil 11 Leucovorin 10 Oxaliplatin 9 Cyclophosphamide 8 pembrolizumab 7 fludarabine 7 Albumin-Bound Paclitaxel 7 Cisplatin 6 Cetuximab 6 Nivolumab 5 durvalumab 4 Taxes 4 Radiosurgery 4 Pemetrexed 4 Capecitabine 4 zimberelimab 3 trastuzumab deruxtecan 3 olaparib 3 irinotecan sucrosofate 3 dehydroftorafur 3 aldesleukin 3 Radiotherapy 3 Immunoglobulin G 3 Exercise 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Neoplasms × Losartan × 30 days × Clear all

NCT04106856 2026-05-12

SHAPER

University of Utah

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡